日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

m(6)A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism

m(6)A修饰的circRAPGEF1与IGF2BP3的相互作用通过重编程天冬氨酸代谢促进肝细胞癌进展

Shi, Juanyi; Mui, Sintim; Yan, Yongcong; Liu, Shaomin; Wen, Kai; He, Chuanchao; Li, Huoming; Liao, Hao; Tao, Meng; Wen, Jiahua; Wang, Weidong; Xu, Xiaoding; Zhou, Zhenyu; Xiao, Zhiyu

Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinoma.

多组学分析表明 OSGEPL1 是肝细胞癌中的一种癌基因

Mui Sintim, Shi Juanyi, Wen Kai, Yan Yongcong, Li Huoming, Wang Weidong, Zhou Zhenyu, Xiao Zhiyu

Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

乐伐替尼在晚期肝细胞癌患者中的应用及耐药机制

Tao, Meng; Han, Jing; Shi, Juanyi; Liao, Hao; Wen, Kai; Wang, Weidong; Mui, Sintim; Li, Huoming; Yan, Yongcong; Xiao, Zhiyu